THOR
Thornburg Premium Income Builder ETF
stock NYSE ETF

Thoratec Corporation, together with its subsidiaries, develops, manufactures, and markets proprietary medical devices used for mechanical circulatory support for the treatment of heart failure patients. The company’s primary product lines include ventricular assist devices, including HeartMate II, an implantable, electrically powered, continuous flow, left ventricular assist device (LVAD) consisting of a rotary blood pump designed to provide intermediate and long-term mechanical circulatory support (MCS); CentriMag an extracorporeal circulatory support device that provides hemodynamic stabilization in patients in need of cardiopulmonary support. It also offers PediMag and PediVAS extracorporeal full-flow acute surgical support platforms incorporating a polycarbonate pump, based on magnetically levitated bearingless motor technology, designed to provide acute surgical support to pediatric patients. In addition, it provides Thoratec Paracorporeal Ventricular Assist Device (PVAD) an external, pulsatile ventricular assist device (VAD), FDA-approved for bridge-to-transplantation (BTT) and post-cardiotomy myocardial recovery; and Thoratec Implantable Ventricular Assist Device (IVAD) an implantable, pulsatile, VAD, FDA-approved for BTT, including home discharge, and post-cardiotomy myocardial recovery and provides left, right or biventricular MCS The company markets its products through cardiovascular sales specialists and distributors in the United States and internationally. Thoratec Corporation was founded in 1976 and is headquartered in Pleasanton, California.